Skip to main content
. 2016 Jul 25;54(8):2169–2171. doi: 10.1128/JCM.00882-16

TABLE 1.

Summary of participating laboratories responses to the technical questionnaire

Analysis yr Extraction method (%) Target combination (%) Real-time apparatus type (%)b No. of cycles (%) Probe type (%) Amplification mixture (%) Use of extraction (%)/amplification control(s) (%)
2010 (n = 32a)
    No. of answers 28 31 30 29 30 30 29
Commercial kit (50) IS481/IS1001 (47) LightCycler (Roche) (37) 40 (55) Hydrolysis (73) Commercial kit (33) 76/100
Automated system (36) IS481 (44) SmartCycler (Cepheid) (26) 45 (41) Hybridization (17) PCR master mix completed with oligosc (67)
In-house method (14) IS481/IS1001/ptxA or ptxA-Pr (6) ABI Prism (Applied Biosystems) (20) 35 (4) SYBR Green (7)
IS481/ptxA (3) Rotor-Gene (10) Beacon (3)
2012 (n = 34a)
    No. of answers 34 34 34 34 34 34 34
Commercial kit (52) IS481/IS1001 (71) LightCycler (Roche) (40) 45 (59) Hydrolysis (79) Commercial kit (62) 84/97
Automated system (38) IS481 (23) SmartCycler (Cepheid) (35) 40 (26) Hybridization (15) PCR master mix completed with oligosc (38)
In-house method (13) IS481/ptxA (3) ABI Prism (Applied Biosystems) (12) 50 (15) SYBR Green (3)
IS481/IS1001/ptxA-Pr/recA-h (3) Rotor-Gene (9) Beacon (3)
a

Participants using RT-PCR methodology are presented. The only laboratory using endpoint PCR method (Genoquick Bordetella Hain LifeScience kit; IS481-IS1001; Perkin Elmer apparatus) is not included in the table.

b

LightCycler 1/2/480; SmartCycler I/II; ABI Prism 7000/7500/7900; Rotor-Gene 6000.

c

Participants used RT-PCR mixture from different suppliers (Applied Biosystems, Roche, Eurogentec) completed with primers and probes from different suppliers.